Sugi Predict

Sugi Predict / Compounds / SCHEMBL1869296

SCHEMBL1869296

SCHEMBL1869296

C=C(c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2B Q14289 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ NR4A1 P22736 1/20 0.58
▸ NR4A2 P43354 1/20 0.58
▸ NR4A3 Q92570 1/20 0.58
▸ MMP3 P08254 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ PTPN1 P18031 1/20 0.50
▸ CDC25B P30305 1/20 0.50
▸ PLK1 P53350 1/20 0.50
▸ CYP1A2 P05177 3/20 0.48
▸ ALDH1A1 P00352 4/20 0.46
▸ TSHR P16473 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ CYP2A6 P11509 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ POLB P06746 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10844527 0.88 ALDH1A1 (0.54) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL1933651 0.87 NR4A1 (0.55) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL31371895 0.87 NR4A1 (0.55) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL5999394 0.83 PTK2B (0.57) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL146735 0.83 NR4A1 (0.61) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL18159929 0.82 GFER (0.50) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL872746 0.82 PTK2B (0.47) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL4201604 0.81 PTK2B (0.60) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL5497000 0.81 PTK2B (0.55) PTK2BL3MBTL1NR4A1NR4A2NR4A3
SCHEMBL273123 0.81 PTK2B (0.55) PTK2BL3MBTL1NR4A1NR4A2NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260003210-A1 DIFFRACTIVE CONTACT LENSES ALCON INC (CH) 2026-01-01 — — US claimed
US-12379611-B2 Diffractive contact lenses ALCON INC. (CH) 2025-08-05 — — US claimed
EP-4356169-A1 MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2024-04-24 — — EP claimed
US-20230004023-A1 DIFFRACTIVE CONTACT LENSES ALCON INC. (CH) 2023-01-05 — — US claimed
WO-2022263994-A1 MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES ALCON INC. (CH) 2022-12-22 — — WO claimed
CN-106632827-B A kind of preparation method of the water-soluble amphiphilic macromolecule with initiation and surface active function 西北工业大学 2019-04-05 — — CN claimed
CN-105646761-A Preparation method of mesoporous polymer nanoparticles 西北工业大学 2016-06-08 — — CN claimed
US-8951712-B2 Resist protective film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-02-10 — — US claimed
US-8829116-B2 Method for producing block copolymers DOW GLOBAL TECHNOLOGIES LLC (US) 2014-09-09 — — US claimed
US-20140080064-A1 RESIST PROTECTIVE FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-03-20 — — US claimed
US-20040024145-A1 Graft copolymers, their preparation and their use BASF AKTIENGESELLSCHAFT (DE) 2004-02-05 — — US claimed
US-20040014872-A1 Bonding agent composition containing solid matter, with radically polymerised block copolymers BASF AKTIENGESELLSCHAFT (DE) 2004-01-22 — — US claimed
US-20030170306-A1 Use of polymeric reaction product BASF AKTIENGESELLSCHAFT (DE) 2003-09-11 — — US claimed
CN-1436204-A Magnetic or magnetisable bonding agent composition EMTEC MAGNETICS GMBH (DE) 2003-08-13 — — CN claimed
CN-1436198-A Method for production of polymerisation reaction product BASF AG (DE) 2003-08-13 — — CN claimed
EP-1294797-A1 MAGNETIC OR MAGNETISABLE BONDING AGENT COMPOSITION EMTEC Magnetics GmbH (HRB 3925) (DE) 2003-03-26 — — EP claimed
US-20030018137-A1 Method for producing a polymeric conversion product BASF AKTIENGESELLSCHAFT (DE) 2003-01-23 — — US claimed
US-6506836-B1 Reacting under free-radical conditions a reaction mixture comprising at least one free-radically reactable monomer (a) in the presence of at least one free-radical initiator and of a compound process for preparing a polymer using said reaction BASF AKTIENGESELLSCHAFT (DE) 2003-01-14 — — US claimed
CN-1329100-A Copolymer type conjugated polymer whose main chain contains double bond, its preparation method and application UNIV WUHAN (CN) 2002-01-02 — — CN claimed
WO-2001096455-A1 MAGNETIC OR MAGNETISABLE BONDING AGENT COMPOSITION EMTEC MAGNETICS GMBH (DE) 2001-12-20 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260003210-A1 DIFFRACTIVE CONTACT LENSES LBR, CRYZ, CRYAA PTK2B 1447/4885L3MBTL1 3896/4885NR4A1 2424/4885
US-20030170306-A1 Use of polymeric reaction product OXSR1, OGFR, CBR1 PTK2B 2000/4885L3MBTL1 2640/4885NR4A1 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.